Cargando…
RNA-based drugs and regulation: Toward a necessary evolution of the definitions issued from the European union legislation
Many RNA-based drugs, both vaccines and non-vaccines, are under development or even approved. They include coding mRNAs and non-coding (nc) RNAs among them antisense oligonucleotides (ASOs), small interfering RNAs (siRNAs), micro-RNAs (miRNAs), small activating RNAs (saRNAs), RNA aptamers and RNA gu...
Autores principales: | Guerriaud, Mathieu, Kohli, Evelyne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618588/ https://www.ncbi.nlm.nih.gov/pubmed/36325384 http://dx.doi.org/10.3389/fmed.2022.1012497 |
Ejemplares similares
-
The Evolution of Legislation in the Field of Medically Assisted Reproduction and Embryo Stem Cell Research in European Union Members
por: Busardò, Francesco Paolo, et al.
Publicado: (2014) -
Smoking Behaviour, Involuntary Smoking, Attitudes towards Smoke-Free Legislations, and Tobacco Control Activities in the European Union
por: Martínez-Sánchez, Jose M., et al.
Publicado: (2010) -
The European Health Union: European Union’s Concern about Health for All. Concepts, Definition, and Scenarios
por: Nabbe, Marie, et al.
Publicado: (2021) -
Risk‐based approach in the revised European Union drinking water legislation: Opportunities for bioanalytical tools
por: Dingemans, Milou ML, et al.
Publicado: (2018) -
How the European Union legislations are tackling the burden of diabetes mellitus: A legal surveillance study
por: Mahrouseh, Nour, et al.
Publicado: (2022)